Accordingly, Pirozzi et al. showed that HTyr (10 mg/kg/day orally, for 5 weeks) exerted anti-inflammatory activity in the liver of rats with nonalcoholic fatty liver disease (NAFLD), by inhibiting liver TNF-α and IL-6 mRNA expressions [134]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.